Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

Clinical trial NCT03300115 · UNKNOWN

Trial details

NCT number: NCT03300115
Sponsor: Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2017-05-18
Primary completion: 2019-06-17
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.